Nasogastric Tube Market
By Nasogastric Tube Type (Levin Catheter, Dobhoff Tube, Moss Tube, and Others),
By Patient (Paediatric, Adult),
By Application (Oncology, Gastroenterology. Diabetes, and Others),
By End Use (Hospitals, Clinics, Home Care),
By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa):
Nasogastric Tube Market - Global Analysis and Forecast 2023-2033
The global Nasogastric tube market showcased a revenue of USD 731.67 billion in 2021 and is projected to witness a compounded annual growth rate (CAGR) of more than 6% over the forecast period of 2023-2033.
Russia-Ukraine War Impact
Market Scope
About the Market
Impact of COVID-19
Global Economic Slowdown
Market Dynamics
Driver
Restrain
Opportunity
Recent Developments
Synopsis
How is this report helpful
FAQ's
Report Coverage
Related Reports
A nasogastric tube is a simple tool to deliver liquid medications and food preparations into the stomach. It is manufactured using plastic, rubber, or other flexible and soft materials. The tube is inserted through the nose and extended to the stomach. This tube is utilized for patients who are unconscious or unable to feed themselves. The rise in the geriatric population, coupled with a surge in chronic disorders and increasing preterm births are primary factors supporting the market growth of nasogastric tubes.
Older or infant populations are most unable to feed themselves, making the nasogastric tube a valuable tool for their nutrition. The rise in chronic disorders such as brain strokes or associated paralysis attacks further propels the need for nasogastric feeding. The tube is also utilized for malnutrition, stomach disorders such as irritable bowel syndrome or ulcers, and even cases of poisoning. A nasogastric tube can also be used to remove poisonous substances or wastes from the stomach. This wide array of applications is supporting the market growth of nasogastric tubes. The main clinical focus on nasogastric tubes is to enhance patient compliance. The recent trends are focusing on making nasogastric tubes flexible and biocompatible enough to be effectively set up in patients who are only partly functional or non-functional. Rejection of nasogastric tubes can come from discomfort, irritation, or emesis. These responses are common due to the material and insertion procedure used for nasogastric tubes. Innovations in making the material more biocompatible or insertion procedures more comfortable can improve patient acceptability.
In 2019, Wound Healing Department at Sharp Memorial Hospital, San Diego, California, prepared and developed certain guidelines for nurses to reduce Hospital-Acquired Nasogastric Tube–Related Pressure Injuries. This was a crucial step to improvise the nasogastric tube insertion procedure and, thus, enhance patient compliance. In line with similar efforts, the Department of Anaesthesiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, India, came up with a newer innovative Sahu's three-in-one combination technique with the use of GlideScope and forward placement of intubated trachea by external laryngeal maneuver, so as to achieve high success rate for Nasogastric tube placement.
Impact of the Russia-Ukraine War on the Nasogastric Tube Market
The nasogastric tube market witness a notable impact in terms of supply and demand due to the ongoing Russia-Ukraine war. Russia and Ukraine were one of the largest suppliers of medical supplies and disruption in economics stability, followed by inflation has cased market hindrance. There is a shortage of nasogastric tubes across the European region. The supply of nasogastric tubes has decreased by 15% whereas the raw material prices has increased by an average of 20% since the start of war. Furthermore, the demand of nasogastric tubes has increased by 50% within the European region with major demand generated from the Russian and Ukrainian region. The increased demand is due to the rising number of injured and physically unfit people in these regions due to war. While the demand has increased, notable supply chain and manufacturing disruption, followed by inflation is limiting the business opportunities.
Nasogastric Tube: Market Scope
The Nasogastric tube market is divided into four segments: type, patient, application, and end-use. Furthermore, these segments are subdivided into respective categories and cross-referenced to North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa for regional analysis. The nasogastric tube type segment is further categorized into (Levin Catheter, Dobhoff Tube, Moss Tube, and Others). The patient segment is segregated into pediatric and adult. Oncology, Gastroenterology, Diabetes, and Others bifurcate the application segment of the Nasogastric tube market. With respect to end users, the industry is analyzed by Hospitals, Clinics, and Home Care. Each segment is further classified into regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The historical dataset of 2018-2022 is provided in the report, whereas the forecast period of 2023-2033 is offered.
Levin Catheter would capture the highest market share within the nasogastric tube type segment
Various models of Nasogastric tubes are used in the market. For instance, Levin catheter and dobhoff are single-lumen nasogastric tubes that are used for one-way nutrition or medication delivery. The double-lumen nasogastric tubes are used for suctioning content out from the stomach, as in cases of poisoning or toxicity. Levin catheter is most preferred due to its small diameter and easy insertion. Dobhoff tube weights its end so as to provide gravity-assisted insertion down the pylorus. Levin catheters capture the highest market share because cases requiring one-way nutrition are more than poisoning cases requiring suction. Further, the small diameter of the Levin catheter tube assures more patient compliance and improved acceptability.
Pediatric patients would capture the highest market share
As per a report presented by WHO in 2022, An estimated 15 million babies are born too early every year. That is more than 1 in 10 babies. Approximately 1 million children die each year due to complications of preterm birth. Many survivors face a lifetime of disability, including learning disabilities and visual and hearing problems. These estimations indicate an increased usage of nasogastric tubes for infant feeding. New-born babies who are born malnourished are also fed using a nasogastric tube. Forecasted years indicate a rise in preterm deliveries due to hectic lifestyles and improper care during pregnancy. These trends are likely to support the market growth of nasogastric tubes for pediatric patients.
Oncology applications would capture the highest market share
Researchers from Nature Reviews Clinical Oncology have reported that the incidence of several early-onset cancers, including tumors of the breast, colon, esophagus, kidney, liver, and pancreas, has dramatically increased around the world. The trend is expected to rise in forecasted years, making way for more cancer care treatments. Nasogastric tubes would thus witness a parallel rise in feeding cancer patients. Cancer or chronic disorders like strokes often leave patients with swallowing difficulty. Cancer treatments also affect digestion and gastric motility. These factors would support nasogastric tube application for oncology cases.
Hospitals would capture the highest end-use market share
Nasogastric tubes are mostly applied to patients who are not fully functional or are bedridden. These include patients recovering from surgery, cancer patients, and patients who are unconscious or preterm infants. These patients are mostly held within hospital settings for treatment. Home care is available for those patients with considerable functionality. A major portion of the non-functional patient population is usually administered to hospitals, thus propelling more distribution of nasogastric tubes for hospital settings.
North America to capture the highest market share in the forecast period
In 2022, the American cancer society reported that approximately 609,360 deaths from cancer are expected in the U.S. in 2022, which is about 1,670 deaths per day. Cancer is the second most common cause of death in the U.S., exceeded only by heart disease. These estimations suggest that North America's cancer patient count is steadily increasing. Similar trends are expected for forecasted years as well. This would propel market growth for nasogastric tubes. The rise in the geriatric population, coupled with the rise in chronic disorders, is further likely to support the market growth of nasogastric tubes within this region.
Impact of COVID-19 on the Nasogastric Tube Industry
COVID-19 presented a severe infection which made patients rely on nasogastric feeding. Hospitals saw a surge in demand for beds, oxygen, and other equipment, including nasogastric tubes. Patients with chronic disorders got even more prone to severe outcomes. Stress due to professional blockage also resulted in the acceleration of chronic disorders. The pandemic has significantly increased the demand for nasogastric tubes.
Nasogastric Tube: Market Dynamics
The market dynamics section of the report covers an in-depth analysis of drivers, restraints, and opportunities impacting the Nasogastric tube market. The report also encompasses major market strategies practiced by the industry, followed by patent analysis, product analysis, competitive benchmarking of companies, PORTER and PESTLE analysis of the Nasogastric tube industry, pricing analysis, and geographic competitiveness to provide a detailed understanding. The major players operating in the market are Andersen Products, Bard Medical, Becton, Dickinson and Company, Cardinal Health, Degania Medical, Guangdong Baihe Medical Technology Co., Ltd., Hangzhou Formed Medical Devices Co., Ltd., Pacific Hospital Supply Co., Ltd., Rontis Medical and SecurMed. These companies cumulatively hold most of the Nasogastric tube market share and actively undergo strategic development, such as new product launches, mergers, collaborations, business expansion, acquisitions, and long-term contracts to ensure market penetration. These companies also largely focus on research and development to gain technological competitiveness in the market. A detailed analysis of these companies is offered in the report.
Driver: Rise in cancer and preterm births
The older population and preterm infants drive the nasogastric tube market. These represent the most dependent population for feeding. A nasogastric tube is used for malnutrition, stomach disorders, and chronic disorders. The geriatric population suffers from digestion problems, slow peristalsis, or chronic conditions such as cardiovascular disorders or stroke conditions. Forecasted years show a rise in the geriatric population, indicating a parallel rise in the use of nasogastric tubes. Recent years have witnessed the most premature births. Forecasted years also expect a similar pattern and thus driving the market growth for nasogastric tubes.
Restrain: Side effects or associated discomfort.
Nasogastric tube usage is mostly associated with discomfort or irritation. Various other side effects are also prevalent, including emesis, retching, tube dislocation, tube perforation, gagging, and skin irritation. These side effects can restrain to market growth of Nasogastric tubes. To ensure patient compliance, nasogastric tubes require specific manufacturing parameters, such as sufficient biocompatibility or flexibility.
Opportunity: Increased demand on the hospital end.
The rise in chronic disorders and the increasing geriatric population would exert more demand on hospital end-use. Nasogastric tubes are used for feeding patients in unconscious states. Surgery, cancer treatments, and preterm births are likely to create more opportunities for nasogastric tube application. Innovation in the material used for nasogastric tubes would open up new horizons of market opportunities.
Nasogastric Tubes Market: Recent Developments
- In China, The Ministry of Economic Affairs (MOEA) announced on January 18 that it had suspended imports of silicon nasogastric tubes because they significantly undercut Taiwan-made products, seriously affecting the development of the local industry.
- Israel-based ENvizion Medical has developed a novel feeding tube navigation system to address complications with insertion procedures.
- In November 2022, Rockfield medical devices announced Receiving FDA Clearance for the Mobility+ Enteral Feeding System.
- Vonco's New Direct Connect Enteral Feeding Device Wins Flexible Packaging Associations Highest Achievement Award for 2022.
Nasogastric Tube Market: Synopsis
The study of the Nasogastric tube market offers revenue and growth data sets of segments provided at the global, regional, and country levels. The report offers the historical data set for 2018-2022 and the forecast period of 2023-2033. For the purpose of analysis, Quadrant Market Insights (QMI) has segregated the Nasogastric tube market into four major segments as follows:
By Nasogastric Tube Type
- Levin Catheter
- Dobhoff Tube
- Moss Tube
- Others
By Patient
- Pediatric
- Adult
By Application
- Oncology
- Gastroenterology
- Diabetes
- Others
By End Use
- Hospitals
- Clinics
- Home Care
The regional analysis of the nasogastric tube market is as follows:
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Israel
Key players operating in the nasogastric tube industry are:
- Andersen Products
- Bard Medical
- Becton, Dickinson, and Company
- Cardinal Health
- Degania Medical
- Guangdong Baihe Medical Technology Co., Ltd.
- Hangzhou Formed Medical Devices Co., Ltd.
- Pacific Hospital Supply Co., Ltd.
- Rontis Medical
- SecurMed
Nasogastric Tube Market: Who Should Purchase, and How It Will Help Readers
- The report is best suited for top-level decision-makers, individuals who are supposed to take a leadership role or require market research to start a business, independent researchers, research institutes, and anyone who wishes to gain detailed strategic insights into the nasogastric tube market.
- This report provides a qualitative and quantitative analysis of the market segments, current trends, estimations, and dynamics of the nasogastric tube market analysis from 2018 to 2033 to identify the prevailing market opportunities.
- Market research and information related to key drivers, restraints, and opportunities are offered.
- Porter's five forces and PESTLE analysis highlight the potency of buyers and suppliers to enable stakeholders' market profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the nasogastric tube segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional and global nasogastric tube industry trends, key players, market segments, application areas, and market growth strategies.
- The report offers insights from primary interviews and CXOs of major industry players. It also offers a comprehensive contact and event repository to ensure future collaborations among industry stakeholders.
Nasogastric Tube Market: Frequently Asked Questions (FAQ)
Q: How big is the nasogastric tube market?
A: The global Nasogastric tube market showcased a revenue of USD 731.67 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 7% over the forecast period of 2023-2033.
Q: Does the report have several nasogastric tube numbers bifurcated by segments and regions?
A: The report offers a total number of nasogastric tube market , further bifurcated into segments and regions. Please refer to the TOC page for more information.
Q: What are the major trends in the nasogastric tube market?
A: Rise in the geriatric population, increasing cases of preterm births, and rise in cancer prevalence are major factors defining the market of Nasogastric tubes within the forecast period.
Q: How can I get the sample Report on the nasogastric tube market?
A: The nasogastric tube market report sample can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report
Q: Is it possible to purchase a specific or customized report as per my needs
A: Yes, it is possible to purchase a specific part of the report or edit the scope of the report at your convenience. Feel free to drop us the mail/talk to our customer support or schedule a conversation to procure a customized report.
Report Coverage
- Nasogastric Tube Type
- Patient
- Application
- End Use
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Increasing detection of cancer cases
- Rise in preterm birth ration
- Rising demand at hospital end
- Side effects and associated discomfort
Andersen Products, Bard Medical, Becton, Dickinson and Company, Cardinal Health, Degania Medical, Guangdong Baihe Medical Technology Co., Ltd., Hangzhou Formed Medical Devices Co., Ltd., Pacific Hospital Supply Co., Ltd., Rontis Medical and SecurMed.
1. Introduction
1.1 Report Description
1.1.1 Definition
1.1.2 Abbreviations
1.2 Key Market Segments
1.3 Benefits to Stakeholders
1.4 Research Methodology
1.4.1 Market Scoping
1.4.1.1 Problem Identification
1.4.1.2 Defining the Market
1.4.2 Market Estimation
1.4.2.1 Data Mining
1.4.2.2 Product Analysis
1.4.2.3 Application Analysis
1.4.2.4 Market Engineering and Forecasting
1.4.2.4.1 Bottom-up Demand Side
1.4.2.4.2 Bottom-up Supply side
1.4.3 Market Authentication
1.4.3.1 Data Triangulation
1.4.3.1.1 Top-down Supply Side
1.4.3.1.2 Top-down Demand Side
1.4.3.1.3 Data Triangulation
1.4.3.2 Primary Insights and Industry feedback
1.4.4 Report Writing
2. Executive Summary
2.1 Market Snapshot
2.2 Macro Trends, Global Economic Factors and Import/Export Insights
2.3 Primary Insights
2.4 Application Insights
2.5 End Use Insights
2.6 Product Insights
2.7 Mode of Purchase Insights
2.8 Regional Insights
3. Market Overview
3.1 Market Segment and Scope
3.2 Top Investment Pockets
3.3 Key Strategic Initiatives
3.4 Nasogastric Tube Market Industry Ecosystem
3.5 Market Evolution
3.6 Patent Analysis
3.7 Technology Landscape
3.8 Regulatory Infrastructure
3.9 Porter’s Analysis
3.9.1 Bargaining Power of Buyer
3.9.2 Bargaining Power of Supplier
3.9.3 Threat of New Entrants
3.9.4 Threat of Substitutes
3.9.5 Industry Rivalry
3.10 PESTLE Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.2 Restrains
3.11.3 Opportunities
3.12 Impact of COVID-19 on nasogastric tube Market
3.13 Russia-Ukraine War Impact on Nasogastric Tube Market
3.14 Growth Share Matrix
3.15 Nasogastric Tube Market Quadrant
4. Nasogastric Tube Market, By Type
4.1 Major Impacting Factors, By Type
4.1.1 Key Market Trends and Growth Factors
4.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.2 Levin Catheter
4.2.1 Key Market Trends and Growth Factors
4.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3 Dobhoff Tube
4.3.1 Key Market Trends and Growth Factors
4.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.4 Moss Tube
4.4.1 Key Market Trends and Growth Factors
4.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.5 Others
4.5.1 Key Market Trends and Growth Factors
4.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5. Nasogastric Tube Market, By Patient
5.1 Major Impacting Factors, By Patient
5.1.1 Key Market Trends and Growth Factors
5.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.2 Pediatric
5.2.1 Key Market Trends and Growth Factors
5.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.3 Adult
5.3.1 Key Market Trends and Growth Factors
5.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6. Nasogastric Tube Market, By Application
6.1 Major Impacting Factors, By Application
6.1.1 Key Market Trends and Growth Factors
6.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.2 Oncology
6.2.1 Key Market Trends and Growth Factors
6.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.3 Gastroenterology
6.3.1 Key Market Trends and Growth Factors
6.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.4 Diabetes
6.4.1 Key Market Trends and Growth Factors
6.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.5 Others
6.5.1 Key Market Trends and Growth Factors
6.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7. Nasogastric Tube Market, By End Use
7.1 Major Impacting Factors, By End Use
7.1.1 Key Market Trends and Growth Factors
7.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.2 Hospitals
7.2.1 Key Market Trends and Growth Factors
7.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.3 Clinics
7.3.1 Key Market Trends and Growth Factors
7.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.4 Home Care
7.4.1 Key Market Trends and Growth Factors
7.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8. Nasogastric Tube Market, By Region
8.1 Global Market Trends and Growth Factors
8.2 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.3 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.6 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.7 North America
8.7.1 Key Market Trends and Growth Factors
8.7.2 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.3 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.7.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.7.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.7.7 U.S.
8.7.7.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.7.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.7.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.7.8 Canada
8.7.8.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.8.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.7.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.7.9 Mexico
8.7.9.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.9.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.7.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8 Europe
8.8.1 Key Market Trends and Growth Factors
8.8.2 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.3 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.8.7 UK
8.8.7.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.7.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.8 Germany
8.8.8.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.8.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.9 France
8.8.9.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.9.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.10 Russia
8.8.10.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.10.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.11 Italy
8.8.11.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.11.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.11.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.11.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.12 Rest of Europe
8.8.12.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.12.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.8.12.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.12.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9 Asia-Pacific
8.9.1 Key Market Trends and Growth Factors
8.9.2 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.3 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.9.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.9.7 China
8.9.7.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.7.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.9.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.8 India
8.9.8.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.8.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.9.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.9 Japan
8.9.9.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.9.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.9.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.10 Australia
8.9.10.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.10.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.9.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.11 Rest of Asia-Pacific
8.9.11.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.11.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.9.11.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.11.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10 Latin America
8.10.1 Key Market Trends and Growth Factors
8.10.2 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.3 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.10.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.10.7 Brazil
8.10.7.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.7.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.10.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.8 Argentina
8.10.8.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.8.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.10.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.9 Mexico
8.10.9.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.9.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.10.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.10 Chile
8.10.10.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.10.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.10.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11 Middle East and Africa
8.11.1 Key Market Trends and Growth Factors
8.11.2 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.3 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.11.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.11.7 South Africa
8.11.7.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.7.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.11.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.8 UAE
8.11.8.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.8.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.11.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.9 Saudi Arabia
8.11.9.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.9.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.11.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.10 Israel
8.11.10.1 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.10.2 Market Size and Forecast, by Patient, 2018-2033, (USD Billion)
8.11.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9. Competitive Benchmarking & Company Profiles
9.1 Competitive Benchmarking
9.1.1 Company Market Share
9.1.2 Product Mapping
9.1.3 Competitive Heat map
9.2 Andersen Products
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Product Offering
9.2.4 Strategic Initiatives
9.2.5 SWOT
9.2.6 Ansoff Matrix
9.3 Bard Medical
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Product Offering
9.3.4 Strategic Initiatives
9.3.5 SWOT
9.3.6 Ansoff Matrix
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Product Offering
9.4.4 Strategic Initiatives
9.4.5 SWOT
9.4.6 Ansoff Matrix
9.5 Cardinal Health
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Product Offering
9.5.4 Strategic Initiatives
9.5.5 SWOT
9.5.6 Ansoff Matrix
9.6 Degania Medical
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Product Offering
9.6.4 Strategic Initiatives
9.6.5 SWOT
9.6.6 Ansoff Matrix
9.7 Guangdong Baihe Medical Technology Co., Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Product Offering
9.7.4 Strategic Initiatives
9.7.5 SWOT
9.7.6 Ansoff Matrix
9.8 Hangzhou Formed Medical Devices Co., Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Product Offering
9.8.4 Strategic Initiatives
9.8.5 SWOT
9.8.6 Ansoff Matrix
9.9 Pacific Hospital Supply Co., Ltd.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Product Offering
9.9.4 Strategic Initiatives
9.9.5 SWOT
9.9.6 Ansoff Matrix
9.10 Rontis Medical
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Product Offering
9.10.4 Strategic Initiatives
9.10.5 SWOT
9.10.6 Ansoff Matrix
9.11 SecurMed
9.11.1 Company Overview
9.11.2 Financial Analysis
9.11.3 Product Offering
9.11.4 Strategic Initiatives
9.11.5 SWOT
9.11.6 Ansoff Matrix
10. Industry Connects and Upcoming Seminars
%20(1).webp)
